‘Using electroceutical treatment to reduce symptoms and improve healing in chronic wounds’ published in Primary Health Care

Use of electroceutical treatment effectively restores the current of injury, expediting normal healing and reducing chronic inflammation, biofilms, infection and associated symptoms, such as pain and high exudate. Clinical outcomes and QoL are improved and there are also economic benefits. Read the publication here: Using electroceutical treatment to reduce symptoms and improve healing in chronic...

‘Breaking the cycle of hard-to-heal wounds with electroceutical treatment’ presentation to the Leg Ulcers: Right Care, Right Time Wounds UK Nurse Symposium

Liz Ovens, Independent Tissue Viability Nurse and Associate Lecturer, Bucks New University delivered a presentation on the clinical and cost-effectiveness of Accel-Heal® on hard-to-heal wounds. View the poster here: Breaking the cycle of hard-to-heal wounds with electroceutical treatment (pdf) Liz Ovens, Independent Tissue Viability Nurse and Associate Lecturer Bucks New University, Wounds UK Bristol Nurse Symposium,...

‘Right Care, Right Time – An evaluation using an electroceutical treatment to determine the clinical outcomes in a large NHS Trust’ poster presented at Wounds UK

Significant wound size reduction and healing. Within the 20 week period following treatment, 84% of all wounds healed and 100% of all wounds < 1 year old prior to treatment healed. Using Accel-Heal® can significantly improve clinical outcomes for patients when used alongside standard therapy. Development of a pathway to be incorporated into Trusts’ formularies...

How to order Accel-Heal and Accel-Heal Solo